Home » Posts tagged with » GSK
Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The deal gives Sandoz global rights to the Zinnat, Zinacef, and Fortum brands in over 100 markets. However, the deal does not include the rights in the US, Australia, and Germany […]

February 13, 2021No CommentRead More

Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK

July 30, 2020 No Comment
Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK

Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to 60 million doses of their jointly developed COVID-19 vaccine candidate. The agreement will be subject to a final contract issued by the British government. The COVID-19 vaccine candidate has been developed by Sanofi in partnership with British […]

Continue reading …

Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership

April 17, 2020 No Comment
Vaccine giants Sanofi, GSK announce COVID-19 vaccine partnership

French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]

Continue reading …